Regno Unito - inglese - myHealthbox

eumedica s.a. - pimozide - tablets - 4 mg - it is an antipsychotic of the diphenylbutyl-piperidine series and is indicated in: chronic schizophrenia, for the treatment of symptoms and prevention of relapse; other psychoses, especially paranoid and monosymptomatic hypochondriacal psychoses (eg delusional parasitosis).

Unione Europea - inglese - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - aripiprazole - schizophrenia - psycholeptics - maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

viatris limited - amisulpride 400mg;   - film coated tablet - 400 mg - active: amisulpride 400mg   excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry white y-1-7000 sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

viatris limited - amisulpride 100mg;   - tablet - 100 mg - active: amisulpride 100mg   excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

viatris limited - amisulpride 200mg;   - tablet - 200 mg - active: amisulpride 200mg   excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

viatris limited - amisulpride 50mg - tablet - 50 mg - active: amisulpride 50mg excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - amisulpride -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - amisulpride -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - amisulpride -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - amisulpride -